MTNB Matinas BioPharma Holdings, Inc.

AMEX
$0.23

Matinas BioPharma Holdings, Inc. (MTNB) is expected to report earnings on November 12, 2026, after the market close.

Matinas BioPharma Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings Inc is a biopharmaceutical company. The Company is engaged in identifying & developing novel pharmaceutical products for the treatment of abnormalities in blood lipids, & the treatment of cardiovascular disease.

Sector

Healthcare